Andrew James Strempler

Andrew James Strempler

Active Director Director DIN 05124259
DIN 05124259 First appointment Aug 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2016
Shareholding value •••• Premium profile

About Andrew James Strempler

Data last updated:

Andrew James Strempler is a Director at Pharmacheck Impex Private Limited (since 2016). The company operates in Pharma. Pharmacheck Impex Private Limited reported revenue of ₹16.87 Cr (FY 2025).

DIN 05124259
Primary Designation Director
Industry Pharma
First Appointment 26 Aug 2016
Oldest Company Age 10 yrs
Largest company Pharmacheck Impex Private Limited · ₹16.87 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharmacheck Impex Private Limited U24239MH2016PTC285203
Director26 Aug 20162016₹16.87 Cr (FY 2025)Active

Board colleagues of Andrew James Strempler

NameDINCompanyDesignation
Mohan Sudhakar Kale03620779Pharmacheck Impex Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pharmacheck Impex Private Limited
Premium access

Shareholding and investment profile for Andrew James Strempler

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Andrew James Strempler

Andrew James Strempler currently holds 1 directorship: Pharmacheck Impex Private Limited (Director, since 26 Aug 2016, revenue ₹16.87 Cr (FY 2025)).

Andrew James Strempler was first appointed on 26 Aug 2016 as Director at Pharmacheck Impex Private Limited.

The current boards of Andrew James Strempler's companies include Mohan Sudhakar Kale (Pharmacheck Impex Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available